| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2023 | He Y, Kaya I, Shariatgorji R, Lundkvist J, Wahlberg LU, Nilsson A, Mamula D, Kehr J, Zareba-Paslawska J, Biverstål H, Chergui K, Zhang X, Andren PE, Svenningsson P. Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents. Nature Communications. 14: 5804. PMID 37726325 DOI: 10.1038/s41467-023-41539-5 | 0.533 | |||
| 2022 | Toskas K, Yaghmaeian-Salmani B, Skiteva O, Paslawski W, Gillberg L, Skara V, Antoniou I, Södersten E, Svenningsson P, Chergui K, Ringnér M, Perlmann T, Holmberg J. PRC2-mediated repression is essential to maintain identity and function of differentiated dopaminergic and serotonergic neurons. Science Advances. 8: eabo1543. PMID 36026451 DOI: 10.1126/sciadv.abo1543 | 0.712 | |||
| 2021 | Seo JS, Mantas I, Svenningsson P, Greengard P. Ependymal cells-CSF flow regulates stress-induced depression. Molecular Psychiatry. PMID 34234280 DOI: 10.1038/s41380-021-01202-1 | 0.375 | |||
| 2020 | Fredholm BB, Svenningsson P. Why target brain adenosine receptors? A historical perspective. Parkinsonism & Related Disorders. 80: S3-S6. PMID 33349578 DOI: 10.1016/j.parkreldis.2020.09.027 | 0.456 | |||
| 2020 | Fredholm BB, Svenningsson P. Why target brain adenosine receptors? A historical perspective. Parkinsonism & Related Disorders. 80: S3-S6. PMID 33349578 DOI: 10.1016/j.parkreldis.2020.09.027 | 0.456 | |||
| 2020 | Kerstens VS, Fazio P, Sundgren M, Matheson GJ, Franzén E, Halldin C, Cervenka S, Svenningsson P, Varrone A. Reliability of dopamine transporter PET measurements with [F]FE-PE2I in patients with Parkinson's disease. Ejnmmi Research. 10: 95. PMID 32797307 DOI: 10.1186/S13550-020-00676-4 | 0.305 | |||
| 2020 | Tiger M, Veldman ER, Ekman CJ, Halldin C, Svenningsson P, Lundberg J. A randomized placebo-controlled PET study of ketamine´s effect on serotonin receptor binding in patients with SSRI-resistant depression. Translational Psychiatry. 10: 159. PMID 32475989 DOI: 10.1038/S41398-020-0844-4 | 0.362 | |||
| 2020 | Sitzia G, Mantas I, Zhang X, Svenningsson P, Chergui K. NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism. Neuropharmacology. 108136. PMID 32474027 DOI: 10.1016/j.neuropharm.2020.108136 | 0.755 | |||
| 2020 | Seo JS, Svenningsson P. Modulation of Ion Channels and Receptors by p11 (S100A10). Trends in Pharmacological Sciences. PMID 32418644 DOI: 10.1016/j.tips.2020.04.004 | 0.341 | |||
| 2020 | Becanovic K, de Donno MV, Sousa V, Tedroff J, Svenningsson P. Effects of a novel psychomotor stabilizer, IRL790, on biochemical measures of synaptic markers and neurotransmission. The Journal of Pharmacology and Experimental Therapeutics. PMID 32358047 DOI: 10.1124/jpet.119.264754 | 0.345 | |||
| 2020 | Zhang X, Mantas I, Fridjonsdottir E, Andrén PE, Chergui K, Svenningsson P. Deficits in Motor Performance, Neurotransmitters and Synaptic Plasticity in Elderly and Experimental Parkinsonian Mice Lacking GPR37. Frontiers in Aging Neuroscience. 12: 84. PMID 32292338 DOI: 10.3389/fnagi.2020.00084 | 0.763 | |||
| 2020 | Fazio P, Ferreira D, Svenningsson P, Halldin C, Farde L, Westman E, Varrone A. High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson's disease cohort. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32020370 DOI: 10.1007/S00259-020-04683-4 | 0.318 | |||
| 2020 | Hulme H, Fridjonsdottir E, Gunnarsdottir H, Vallianatou T, Zhang X, Wadensten H, Shariatgorji R, Nilsson A, Bezard E, Svenningsson P, Andrén PE. Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy. Neurobiology of Disease. 104738. PMID 31927144 DOI: 10.1016/j.nbd.2020.104738 | 0.324 | |||
| 2019 | Mantas I, Yang Y, Mannoury-la-Cour C, Millan MJ, Zhang X, Svenningsson P. Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia. Neuropharmacology. 107829. PMID 31666199 DOI: 10.1016/j.neuropharm.2019.107829 | 0.384 | |||
| 2019 | Lazarevic V, Mantas I, Flais I, Svenningsson P. Fluoxetine Suppresses Glutamate- and GABA-Mediated Neurotransmission by Altering SNARE Complex. International Journal of Molecular Sciences. 20. PMID 31480244 DOI: 10.3390/ijms20174247 | 0.339 | |||
| 2019 | Baek JH, Mamula D, Tingstam B, Pereira M, He Y, Svenningsson P. GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson's Disease Patients. Frontiers in Neuroscience. 13: 697. PMID 31333410 DOI: 10.3389/fnins.2019.00697 | 0.302 | |||
| 2019 | Paslawski W, Zareba-Paslawska J, Zhang X, Hölzl K, Wadensten H, Shariatgorji M, Janelidze S, Hansson O, Forsgren L, Andrén PE, Svenningsson P. α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients. Proceedings of the National Academy of Sciences of the United States of America. PMID 31270237 DOI: 10.1073/Pnas.1821409116 | 0.315 | |||
| 2019 | Vallianatou T, Shariatgorji M, Nilsson A, Fridjonsdottir E, Källback P, Schintu N, Svenningsson P, Andrén PE. Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31009936 DOI: 10.1038/S41386-019-0397-5 | 0.317 | |||
| 2019 | Calvo-Garrido J, Maffezzini C, Schober FA, Clemente P, Uhlin E, Kele M, Stranneheim H, Lesko N, Bruhn H, Svenningsson P, Falk A, Wedell A, Freyer C, Wredenberg A. SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation. Stem Cell Reports. PMID 30827875 DOI: 10.1016/j.stemcr.2019.01.023 | 0.333 | |||
| 2018 | Hertz E, Terenius L, Vukojević V, Svenningsson P. GPR37 and GPR37L1 differently interact with dopamine 2 receptors in live cells. Neuropharmacology. 152: 51-57. PMID 30423289 DOI: 10.1016/j.neuropharm.2018.11.009 | 0.361 | |||
| 2018 | Varnäs K, Cselényi Z, Jucaite A, Halldin C, Svenningsson P, Farde L, Varrone A. PET imaging of [C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30270409 DOI: 10.1007/S00259-018-4161-6 | 0.309 | |||
| 2018 | Björkhem I, Patra K, Boxer AL, Svenningsson P. 24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome. Frontiers in Neurology. 9: 756. PMID 30245667 DOI: 10.3389/fneur.2018.00756 | 0.32 | |||
| 2018 | Siebzehnrübl FA, Raber KA, Urbach YK, Schulze-Krebs A, Canneva F, Moceri S, Habermeyer J, Achoui D, Gupta B, Steindler DA, Stephan M, Nguyen HP, Bonin M, Riess O, Bauer A, ... ... Svenningsson P, et al. Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition. Proceedings of the National Academy of Sciences of the United States of America. PMID 30150378 DOI: 10.1073/Pnas.1807962115 | 0.317 | |||
| 2018 | Zhang X, Mantas I, Alvarsson A, Yoshitake T, Shariatgorji M, Pereira M, Nilsson A, Kehr J, Andrén PE, Millan MJ, Chergui K, Svenningsson P. Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine. Frontiers in Pharmacology. 9: 166. PMID 29545750 DOI: 10.3389/Fphar.2018.00166 | 0.779 | |||
| 2018 | Fazio P, Svenningsson P, Cselényi Z, Halldin C, Farde L, Varrone A. Nigrostriatal dopamine transporter availability in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29436751 DOI: 10.1002/Mds.27316 | 0.325 | |||
| 2017 | Yao N, Skiteva O, Zhang X, Svenningsson P, Chergui K. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit. Molecular Psychiatry. PMID 29158578 DOI: 10.1038/mp.2017.239 | 0.339 | |||
| 2017 | Svenningsson P, Pålhagen S, Mathé AA. Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson's Disease with Comorbid Depression versus Patients with Major Depressive Disorder. Frontiers in Psychiatry. 8: 102. PMID 28659833 DOI: 10.3389/fpsyt.2017.00102 | 0.312 | |||
| 2017 | Leinartaité L, Svenningsson P. Folding Underlies Bidirectional Role of GPR37/Pael-R in Parkinson Disease. Trends in Pharmacological Sciences. PMID 28629580 DOI: 10.1016/j.tips.2017.05.006 | 0.375 | |||
| 2017 | Rame M, Caudal D, Schenker E, Svenningsson P, Spedding M, Jay TM, Godsil BP. Clozapine counteracts a ketamine-induced depression of hippocampal-prefrontal neuroplasticity and alters signaling pathway phosphorylation. Plos One. 12: e0177036. PMID 28472198 DOI: 10.1371/Journal.Pone.0177036 | 0.347 | |||
| 2017 | Devor A, Andreassen OA, Wang Y, Mäki-Marttunen T, Smeland OB, Fan CC, Schork AJ, Holland D, Thompson WK, Witoelar A, Chen CH, Desikan RS, McEvoy LK, Djurovic S, Greengard P, ... Svenningsson P, et al. Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia. Molecular Psychiatry. PMID 28348379 DOI: 10.1038/Mp.2017.33 | 0.495 | |||
| 2017 | Veldman ER, Svedberg MM, Svenningsson P, Lundberg J. Distribution and levels of 5-HT1B receptors in anterior cingulate cortex of patients with bipolar disorder, major depressive disorder and schizophrenia - An autoradiography study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28318898 DOI: 10.1016/j.euroneuro.2017.02.011 | 0.327 | |||
| 2017 | Monnot C, Zhang X, Nikkhou-Aski S, Damberg P, Svenningsson P. Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism. Experimental Neurology. PMID 28223037 DOI: 10.1016/j.expneurol.2017.02.014 | 0.328 | |||
| 2017 | Green H, Zhang X, Tiklova K, Volakakis N, Brodin L, Berg L, Greengard P, Perlmann T, Svenningsson P. Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 28137881 DOI: 10.1073/pnas.1621218114 | 0.482 | |||
| 2017 | Monnot C, Zhang X, Nikkhou Aski S, Damberg P, Svenningsson P. Loss of dopamine mediated by 6-hydroxydopamine alters structural and functional connectivity in a model of parkinsonism European Neuropsychopharmacology. 27: S52-S53. DOI: 10.1016/S0924-977X(17)30123-2 | 0.327 | |||
| 2016 | Milosevic A, Liebmann T, Knudsen M, Schintu N, Svenningsson P, Greengard P. Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain. The Journal of Comparative Neurology. PMID 27616678 DOI: 10.1002/cne.24113 | 0.493 | |||
| 2016 | Haack TB, Ignatius E, Calvo-Garrido J, Iuso A, Isohanni P, Maffezzini C, Lönnqvist T, Suomalainen A, Gorza M, Kremer LS, Graf E, Hartig M, Berutti R, Paucar M, Svenningsson P, et al. Absence of the Autophagy Adaptor SQSTM1/p62 Causes Childhood-Onset Neurodegeneration with Ataxia, Dystonia, and Gaze Palsy. American Journal of Human Genetics. PMID 27545679 DOI: 10.1016/j.ajhg.2016.06.026 | 0.31 | |||
| 2016 | Bigio B, Mathé AA, Sousa VC, Zelli D, Svenningsson P, McEwen BS, Nasca C. Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance. Proceedings of the National Academy of Sciences of the United States of America. PMID 27354525 DOI: 10.1073/pnas.1603111113 | 0.336 | |||
| 2016 | Marongiu R, Arango-Lievano M, Francardo V, Morgenstern P, Zhang X, Cenci MA, Svenningsson P, Greengard P, Kaplitt MG. Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787858 DOI: 10.1073/Pnas.1524387113 | 0.695 | |||
| 2016 | Schintu N, Zhang X, Alvarsson A, Marongiu R, Kaplitt MG, Greengard P, Svenningsson P. p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787846 DOI: 10.1073/Pnas.1524303113 | 0.683 | |||
| 2016 | Green H, Brodin L, Greengard P, Berg L, Svenningsson P. Abstract # 1792 Peripheral inflammatory mediators and p11 levels in peripheral blood mononuclear cells from patients with Parkinson’s disease Brain, Behavior, and Immunity. 57: e24-e25. DOI: 10.1016/j.bbi.2016.07.083 | 0.448 | |||
| 2015 | Yang J, Hertz E, Zhang X, Leinartaité L, Lundius EG, Li J, Svenningsson P. Overexpression of α-synuclein simultaneously increases glutamate NMDA receptor phosphorylation and reduces glucocerebrosidase activity. Neuroscience Letters. PMID 26610904 DOI: 10.1016/j.neulet.2015.11.023 | 0.308 | |||
| 2015 | Stroth N, Svenningsson P. S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26499172 DOI: 10.1016/j.euroneuro.2015.10.003 | 0.358 | |||
| 2015 | Alvarsson A, Zhang X, Stan TL, Schintu N, Kadkhodaei B, Millan MJ, Perlmann T, Svenningsson P. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, l-DOPA Responsivity, and Glutamatergic Neurotransmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 14057-69. PMID 26468205 DOI: 10.1523/JNEUROSCI.1312-15.2015 | 0.429 | |||
| 2015 | Pereira M, Martynhak BJ, Andreatini R, Svenningsson P. 5-HT6 receptor agonism facilitates emotional learning. Frontiers in Pharmacology. 6: 200. PMID 26441657 DOI: 10.3389/fphar.2015.00200 | 0.348 | |||
| 2015 | Caudal D, Alvarsson A, Björklund A, Svenningsson P. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons. Experimental Neurology. 273: 243-252. PMID 26363495 DOI: 10.1016/j.expneurol.2015.09.002 | 0.359 | |||
| 2015 | Alvarsson A, Caudal D, Björklund A, Svenningsson P. Emotional memory impairments induced by AAV-mediated overexpression of human α-synuclein in dopaminergic neurons of the ventral tegmental area. Behavioural Brain Research. 296: 129-133. PMID 26341317 DOI: 10.1016/j.bbr.2015.08.034 | 0.307 | |||
| 2015 | Stan TL, Sousa VC, Zhang X, Ono M, Svenningsson P. Lurasidone and fluoxetine reduce novelty-induced hypophagia and NMDA receptor subunit and PSD-95 expression in mouse brain. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26256011 DOI: 10.1016/j.euroneuro.2015.07.007 | 0.391 | |||
| 2015 | Laguna A, Schintu N, Nobre A, Alvarsson A, Volakakis N, Jacobsen JK, Gómez-Galán M, Sopova E, Joodmardi E, Yoshitake T, Deng Q, Kehr J, Ericson J, Svenningsson P, Shupliakov O, et al. Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease. Nature Neuroscience. 18: 826-35. PMID 25915474 DOI: 10.1038/nn.4004 | 0.564 | |||
| 2015 | Varrone A, Svenningsson P, Marklund P, Fatouros-Bergman H, Forsberg A, Halldin C, Nilsson LG, Farde L. 5-HT1B receptor imaging and cognition: a positron emission tomography study in control subjects and Parkinson's disease patients. Synapse (New York, N.Y.). 69: 365-74. PMID 25914348 DOI: 10.1002/Syn.21823 | 0.335 | |||
| 2015 | Kiselycznyk C, Jury NJ, Halladay LR, Nakazawa K, Mishina M, Sprengel R, Grant SG, Svenningsson P, Holmes A. NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism. Behavioural Brain Research. 287: 89-95. PMID 25800971 DOI: 10.1016/J.Bbr.2015.03.023 | 0.38 | |||
| 2015 | Svenningsson P, Rosenblad C, Af Edholm Arvidsson K, Wictorin K, Keywood C, Shankar B, Lowe DA, Björklund A, Widner H. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study. Brain : a Journal of Neurology. 138: 963-73. PMID 25669730 DOI: 10.1093/Brain/Awu409 | 0.311 | |||
| 2014 | Svenningsson P. Reductions of p11 and 5-HT1B receptor availability in limbic brain regions in cocaine dependence. Biological Psychiatry. 76: 763-4. PMID 25442058 DOI: 10.1016/j.biopsych.2014.08.011 | 0.334 | |||
| 2014 | Stan TL, Alvarsson A, Branzell N, Sousa VC, Svenningsson P. NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum. Translational Psychiatry. 4: e395. PMID 24893066 DOI: 10.1038/tp.2014.39 | 0.32 | |||
| 2014 | Mavrikaki M, Schintu N, Nomikos GG, Panagis G, Svenningsson P. Ropinirole regulates emotionality and neuronal activity markers in the limbic forebrain. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1981-93. PMID 24852388 DOI: 10.1017/S1461145714000728 | 0.415 | |||
| 2014 | Svenningsson P, Berg L, Matthews D, Ionescu DF, Richards EM, Niciu MJ, Malinger A, Toups M, Manji H, Trivedi MH, Zarate CA, Greengard P. Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram. Molecular Psychiatry. 19: 962-4. PMID 24614495 DOI: 10.1038/Mp.2014.13 | 0.422 | |||
| 2014 | Shrestha SS, Liow JS, Lu S, Jenko K, Gladding RL, Svenningsson P, Morse CL, Zoghbi SS, Pike VW, Innis RB. (11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 141-6. PMID 24385311 DOI: 10.2967/jnumed.113.125831 | 0.348 | |||
| 2014 | Shrestha SS, Pine DS, Luckenbaugh DA, Varnäs K, Henter ID, Innis RB, Mathé AA, Svenningsson P. Antidepressant effects on serotonin 1A/1B receptors in the rat brain using a gene x environment model. Neuroscience Letters. 559: 163-8. PMID 24287374 DOI: 10.1016/j.neulet.2013.11.034 | 0.355 | |||
| 2014 | Mavrikaki M, Schintu N, Kastellakis A, Nomikos GG, Svenningsson P, Panagis G. Effects of lithium and aripiprazole on brain stimulation reward and neuroplasticity markers in the limbic forebrain. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 630-8. PMID 24275700 DOI: 10.1016/j.euroneuro.2013.10.014 | 0.354 | |||
| 2014 | Varrone A, Svenningsson P, Forsberg A, Varnäs K, Tiger M, Nakao R, Halldin C, Nilsson LG, Farde L. Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson's disease. Neurobiology of Aging. 35: 867-75. PMID 24126162 DOI: 10.1016/J.Neurobiolaging.2013.08.025 | 0.324 | |||
| 2013 | Svenningsson P, Kim Y, Warner-Schmidt J, Oh YS, Greengard P. p11 and its role in depression and therapeutic responses to antidepressants. Nature Reviews. Neuroscience. 14: 673-80. PMID 24002251 DOI: 10.1038/Nrn3564 | 0.779 | |||
| 2013 | Kiselycznyk C, Zhang X, Huganir RL, Holmes A, Svenningsson P. Reduced phosphorylation of GluA1 subunits relates to anxiety-like behaviours in mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 919-24. PMID 23360771 DOI: 10.1017/S1461145712001174 | 0.566 | |||
| 2013 | Kadkhodaei B, Alvarsson A, Schintu N, Ramsköld D, Volakakis N, Joodmardi E, Yoshitake T, Kehr J, Decressac M, Björklund A, Sandberg R, Svenningsson P, Perlmann T. Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America. 110: 2360-5. PMID 23341612 DOI: 10.1073/Pnas.1221077110 | 0.573 | |||
| 2013 | Eriksson TM, Alvarsson A, Stan TL, Zhang X, Hascup KN, Hascup ER, Kehr J, Gerhardt GA, Warner-Schmidt J, Arango-Lievano M, Kaplitt MG, Ogren SO, Greengard P, Svenningsson P. Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11. Molecular Psychiatry. 18: 1096-105. PMID 23032875 DOI: 10.1038/Mp.2012.130 | 0.776 | |||
| 2012 | Schintu N, Zhang X, Svenningsson P. Studies of depression-related states in animal models of Parkinsonism. Journal of Parkinson's Disease. 2: 87-106. PMID 23939436 DOI: 10.3233/JPD-2012-12076 | 0.302 | |||
| 2012 | Machaczka M, Arce MP, Rucinska M, Yoshitake T, Kehr J, Jurczak W, Skotnicki AB, Månsson JE, Tylki-Szymanska A, Svenningsson P. A twelve-year follow-up study on a case of early-onset parkinsonism preceding clinical manifestation of Gaucher disease. Jimd Reports. 3: 53-7. PMID 23430873 DOI: 10.1007/8904_2011_48 | 0.486 | |||
| 2012 | Liebmann T, Kruusmägi M, Sourial-Bassillious N, Bondar A, Svenningsson P, Flajolet M, Greengard P, Scott L, Brismar H, Aperia A. A noncanonical postsynaptic transport route for a GPCR belonging to the serotonin receptor family. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 17998-8008. PMID 23238716 DOI: 10.1523/JNEUROSCI.1804-12.2012 | 0.485 | |||
| 2012 | Egeland M, Zhang X, Millan MJ, Mocaer E, Svenningsson P. Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice. Journal of Neurochemistry. 123: 811-23. PMID 22957735 DOI: 10.1111/jnc.12011 | 0.415 | |||
| 2012 | Nilsson A, Stroth N, Zhang X, Qi H, Fälth M, Sköld K, Hoyer D, Andrén PE, Svenningsson P. Neuropeptidomics of mouse hypothalamus after imipramine treatment reveal somatostatin as a potential mediator of antidepressant effects. Neuropharmacology. 62: 347-57. PMID 21856315 DOI: 10.1016/J.Neuropharm.2011.08.004 | 0.373 | |||
| 2012 | Melas PA, Rogdaki M, Lennartsson A, Björk K, Qi H, Witasp A, Werme M, Wegener G, Mathé AA, Svenningsson P, Lavebratt C. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 669-79. PMID 21682946 DOI: 10.1017/S1461145711000940 | 0.351 | |||
| 2012 | Eriksson TM, Delagrange P, Spedding M, Popoli M, Mathé AA, Ögren SO, Svenningsson P. Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Molecular Psychiatry. 17: 173-84. PMID 21242991 DOI: 10.1038/Mp.2010.131 | 0.324 | |||
| 2012 | Sousa V, Egeland M, Svenningsson P. P.2.016 Changes in basal and fluoxetine-induced adult neurogenesis and depression-related behaviours in transgenic S100B over-expressing mice European Neuropsychopharmacology. 22: S45-S46. DOI: 10.1016/S0924-977X(12)70048-2 | 0.33 | |||
| 2011 | Di Cara B, Maggio R, Aloisi G, Rivet JM, Lundius EG, Yoshitake T, Svenningsson P, Brocco M, Gobert A, De Groote L, Cistarelli L, Veiga S, De Montrion C, Rodriguez M, Galizzi JP, et al. Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA). The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 16928-40. PMID 22114263 DOI: 10.1523/JNEUROSCI.2502-11.2011 | 0.393 | |||
| 2011 | Szegedi V, Juhász G, Zhang X, Barkóczi B, Qi H, Madeira A, Kapus G, Svenningsson P, Spedding M, Penke B. Tianeptine potentiates AMPA receptors by activating CaMKII and PKA via the p38, p42/44 MAPK and JNK pathways. Neurochemistry International. 59: 1109-22. PMID 22056552 DOI: 10.1016/j.neuint.2011.10.008 | 0.398 | |||
| 2011 | Kiselycznyk C, Svenningsson P, Delpire E, Holmes A. Genetic, pharmacological and lesion analyses reveal a selective role for corticohippocampal GLUN2B in a novel repeated swim stress paradigm. Neuroscience. 193: 259-68. PMID 21704131 DOI: 10.1016/j.neuroscience.2011.06.015 | 0.342 | |||
| 2011 | Zhang X, Egeland M, Svenningsson P. Antidepressant-like properties of sarizotan in experimental Parkinsonism. Psychopharmacology. 218: 621-34. PMID 21647579 DOI: 10.1007/s00213-011-2356-7 | 0.374 | |||
| 2011 | Zhang X, Andren PE, Glennon RA, Svenningsson P. Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism. The Journal of Comparative Neurology. 519: 1816-27. PMID 21452237 DOI: 10.1002/Cne.22605 | 0.341 | |||
| 2011 | Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum. Neuropharmacology. 61: 442-50. PMID 21300076 DOI: 10.1016/j.neuropharm.2011.01.046 | 0.726 | |||
| 2011 | Björk K, Svenningsson P. Modulation of monoamine receptors by adaptor proteins and lipid rafts: role in some effects of centrally acting drugs and therapeutic agents. Annual Review of Pharmacology and Toxicology. 51: 211-42. PMID 20887195 DOI: 10.1146/annurev-pharmtox-010510-100520 | 0.346 | |||
| 2011 | Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. P.2.b.019 Ablated neurogenic response to fluoxetine in female p11 knockout mice European Neuropsychopharmacology. 21: S378. DOI: 10.1016/S0924-977X(11)70607-1 | 0.73 | |||
| 2011 | Alvarsson A, Eriksson T, Stan T, Hascup K, Hascup E, Gerhardt G, Svenningsson P. P.1.c.041 The effects of 5-HT1B receptor modulation on glutamatergic neurotransmission in vivo European Neuropsychopharmacology. 21: S276-S277. DOI: 10.1016/S0924-977X(11)70432-1 | 0.673 | |||
| 2010 | Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Arango-Llievano M, Ghose S, Vernov M, Stavarache M, Stavarche M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Science Translational Medicine. 2: 54ra76. PMID 20962330 DOI: 10.1126/Scitranslmed.3001079 | 0.805 | |||
| 2010 | Warner-Schmidt JL, Chen EY, Zhang X, Marshall JJ, Morozov A, Svenningsson P, Greengard P. A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biological Psychiatry. 68: 528-35. PMID 20591415 DOI: 10.1016/J.Biopsych.2010.04.029 | 0.747 | |||
| 2010 | Lauth M, Rohnalter V, Bergström A, Kooshesh M, Svenningsson P, Toftgård R. Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels. Molecular Pharmacology. 78: 486-96. PMID 20558592 DOI: 10.1124/mol.110.066431 | 0.302 | |||
| 2010 | Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biological Psychiatry. 67: 1048-56. PMID 20227680 DOI: 10.1016/j.biopsych.2010.01.024 | 0.739 | |||
| 2010 | Björk K, Sjögren B, Svenningsson P. Regulation of serotonin receptor function in the nervous system by lipid rafts and adaptor proteins. Experimental Cell Research. 316: 1351-6. PMID 20211176 DOI: 10.1016/j.yexcr.2010.02.034 | 0.333 | |||
| 2010 | Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S, Vernov M, Stavarache M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens (Science Translational Medicine (2010) 2, (62er4)) Science Translational Medicine. 2. DOI: 10.1126/Scitranslmed.3001996 | 0.784 | |||
| 2010 | Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Llievano M, Ghose S, Vernov M, Stavarche M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens (Science Translational Medicine (2010) 2, (55er3)) Science Translational Medicine. 2. DOI: 10.1126/scitranslmed.3001841 | 0.775 | |||
| 2010 | Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. P.1.006 Neurogenic and chronic behavioural effects of fluoxetine are attenuated in p11 KO mice European Neuropsychopharmacology. 20: S6-S7. DOI: 10.1016/S0924-977X(10)70009-2 | 0.737 | |||
| 2009 | Warner-Schmidt JL, Flajolet M, Maller A, Chen EY, Qi H, Svenningsson P, Greengard P. Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1937-46. PMID 19211900 DOI: 10.1523/JNEUROSCI.5343-08.2009 | 0.767 | |||
| 2009 | Nilsson A, Fälth M, Zhang X, Kultima K, Sköld K, Svenningsson P, Andrén PE. Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. Molecular & Cellular Proteomics : McP. 8: 1094-104. PMID 19131325 DOI: 10.1074/mcp.M800454-MCP200 | 0.343 | |||
| 2009 | Kindlundh-Högberg AM, Zhang X, Svenningsson P. S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 201-15. PMID 18812013 DOI: 10.1017/S1461145708009437 | 0.37 | |||
| 2009 | Qi H, Mailliet F, Spedding M, Rocher C, Zhang X, Delagrange P, McEwen B, Jay TM, Svenningsson P. Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology. 56: 37-46. PMID 18657555 DOI: 10.1016/j.neuropharm.2008.06.068 | 0.328 | |||
| 2009 | Ögren S, Eriksson T, Kehr J, Svenningsson P, Stiedl O. S.2.03 The role of 5-HT1A receptors in emotional memory: implications for anxiety and depression European Neuropsychopharmacology. 19: S115-S116. DOI: 10.1016/S0924-977X(09)70125-7 | 0.483 | |||
| 2009 | Eriksson TM, Youn J, Elvander-Tottie E, Sjögren B, Ekström JC, Ögren SO, Svenningsson P, Stiedl O. P.1.10 Stimulation of 5-HT7 receptors facilitates emotional contextual learning European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70013-6 | 0.301 | |||
| 2008 | Eriksson TM, Golkar A, Ekström JC, Svenningsson P, Ogren SO. 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. European Journal of Pharmacology. 596: 107-10. PMID 18789922 DOI: 10.1016/J.Ejphar.2008.08.026 | 0.32 | |||
| 2008 | Bateup HS, Svenningsson P, Kuroiwa M, Gong S, Nishi A, Heintz N, Greengard P. Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nature Neuroscience. 11: 932-9. PMID 18622401 DOI: 10.1038/Nn.2153 | 0.738 | |||
| 2008 | Sjögren B, Csöregh L, Svenningsson P. Cholesterol reduction attenuates 5-HT1A receptor-mediated signaling in human primary neuronal cultures. Naunyn-Schmiedeberg's Archives of Pharmacology. 378: 441-6. PMID 18607571 DOI: 10.1007/s00210-008-0323-6 | 0.367 | |||
| 2008 | Zhang X, Andren PE, Chergui K, Svenningsson P. Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease. Neuropharmacology. 54: 1143-52. PMID 18423776 DOI: 10.1016/j.neuropharm.2008.03.005 | 0.748 | |||
| 2008 | Ogren SO, Eriksson TM, Elvander-Tottie E, D'Addario C, Ekström JC, Svenningsson P, Meister B, Kehr J, Stiedl O. The role of 5-HT(1A) receptors in learning and memory. Behavioural Brain Research. 195: 54-77. PMID 18394726 DOI: 10.1016/j.bbr.2008.02.023 | 0.56 | |||
| 2008 | Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission. Neuropharmacology. 54: 1041-50. PMID 18394658 DOI: 10.1016/j.neuropharm.2008.02.007 | 0.338 | |||
| 2008 | Zhang X, Andren PE, Greengard P, Svenningsson P. Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. 105: 2163-8. PMID 18256188 DOI: 10.1073/pnas.0711839105 | 0.554 | |||
| 2008 | Millan MJ, Svenningsson P, Ashby CR, Hill M, Egeland M, Dekeyne A, Brocco M, Di Cara B, Lejeune F, Thomasson N, Munoz C, Mocaër E, Crossman A, Cistarelli L, Girardon S, et al. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo. The Journal of Pharmacology and Experimental Therapeutics. 324: 600-11. PMID 18024787 DOI: 10.1124/jpet.107.132563 | 0.381 | |||
| 2008 | Smith DG, Qi H, Svenningsson P, Wade M, Davis RJ, Gehlert DR, Nomikos GG. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice. Synapse (New York, N.Y.). 62: 128-36. PMID 18000809 DOI: 10.1002/syn.20473 | 0.432 | |||
| 2007 | Svenningsson P, Bateup H, Qi H, Takamiya K, Huganir RL, Spedding M, Roth BL, McEwen BS, Greengard P. Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. The European Journal of Neuroscience. 26: 3509-17. PMID 18088278 DOI: 10.1111/J.1460-9568.2007.05952.X | 0.788 | |||
| 2007 | Nilsson A, Sköld K, Sjögren B, Svensson M, Pierson J, Zhang X, Caprioli RM, Buijs J, Persson B, Svenningsson P, Andrén PE. Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins. Journal of Proteome Research. 6: 3952-61. PMID 17877381 DOI: 10.1021/Pr070189E | 0.342 | |||
| 2007 | Kindlundh-Högberg AM, Schiöth HB, Svenningsson P. Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain. Neurotoxicology. 28: 1158-69. PMID 17692920 DOI: 10.1016/j.neuro.2007.07.002 | 0.337 | |||
| 2007 | Zhang X, Andren PE, Svenningsson P. Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model. Physiology & Behavior. 92: 29-33. PMID 17588622 DOI: 10.1016/j.physbeh.2007.05.033 | 0.401 | |||
| 2007 | Witkovsky P, Svenningsson P, Yan L, Bateup H, Silver R. Cellular localization and function of DARPP-32 in the rodent retina. The European Journal of Neuroscience. 25: 3233-42. PMID 17552992 DOI: 10.1111/J.1460-9568.2007.05571.X | 0.721 | |||
| 2007 | Svenningsson P, Tzavara ET, Qi H, Carruthers R, Witkin JM, Nomikos GG, Greengard P. Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 4201-9. PMID 17428998 DOI: 10.1523/Jneurosci.3110-06.2007 | 0.499 | |||
| 2007 | Sjögren B, Svenningsson P. Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells. Acta Physiologica (Oxford, England). 190: 47-53. PMID 17428232 DOI: 10.1111/j.1365-201X.2007.01687.x | 0.32 | |||
| 2007 | Agid Y, Buzsáki G, Diamond DM, Frackowiak R, Giedd J, Girault JA, Grace A, Lambert JJ, Manji H, Mayberg H, Popoli M, Prochiantz A, Richter-Levin G, Somogyi P, Spedding M, ... Svenningsson P, et al. How can drug discovery for psychiatric disorders be improved? Nature Reviews. Drug Discovery. 6: 189-201. PMID 17330070 DOI: 10.1038/Nrd2217 | 0.482 | |||
| 2007 | Svenningsson P, Greengard P. p11 (S100A10)--an inducible adaptor protein that modulates neuronal functions. Current Opinion in Pharmacology. 7: 27-32. PMID 17085073 DOI: 10.1016/j.coph.2006.10.001 | 0.497 | |||
| 2007 | Eriksson TM, Elvander-Tottie E, Budd JC, Sjögren B, Svenningsson P, gren SOö. P.1.c.048 5-HT7 receptors interact with NMDA and 5-HT1A receptor-dependent emotional learning and exploratory activity in mice European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70372-3 | 0.357 | |||
| 2007 | Chergui K, Fredholm BB, Svenningsson P. Many ways to Rome - multiple approaches to novel drugs Current Opinion in Pharmacology. 7: 1-2. DOI: 10.1016/j.coph.2006.12.002 | 0.4 | |||
| 2006 | Sjögren B, Hamblin MW, Svenningsson P. Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors. European Journal of Pharmacology. 552: 1-10. PMID 17064686 DOI: 10.1016/J.Ejphar.2006.08.069 | 0.321 | |||
| 2006 | Yan L, Bobula JM, Svenningsson P, Greengard P, Silver R. DARPP-32 involvement in the photic pathway of the circadian system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9434-8. PMID 16971527 DOI: 10.1523/JNEUROSCI.2538-06.2006 | 0.481 | |||
| 2006 | Kindlundh-Högberg AM, Svenningsson P, Schiöth HB. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain. Neuropharmacology. 51: 838-47. PMID 16820177 DOI: 10.1016/j.neuropharm.2006.05.026 | 0.387 | |||
| 2006 | Zhang X, Andren PE, Svenningsson P. Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease. Brain Research. 1095: 207-10. PMID 16725125 DOI: 10.1016/j.brainres.2006.04.019 | 0.341 | |||
| 2006 | Allen PB, Zachariou V, Svenningsson P, Lepore AC, Centonze D, Costa C, Rossi S, Bender G, Chen G, Feng J, Snyder GL, Bernardi G, Nestler EJ, Yan Z, Calabresi P, et al. Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience. 140: 897-911. PMID 16600521 DOI: 10.1016/J.Neuroscience.2006.02.067 | 0.737 | |||
| 2006 | Zhang Y, Svenningsson P, Picetti R, Schlussman SD, Nairn AC, Ho A, Greengard P, Kreek MJ. Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2645-51. PMID 16525043 DOI: 10.1523/Jneurosci.3923-05.2006 | 0.607 | |||
| 2006 | Sköld K, Svensson M, Nilsson A, Zhang X, Nydahl K, Caprioli RM, Svenningsson P, Andrén PE. Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. Journal of Proteome Research. 5: 262-9. PMID 16457591 DOI: 10.1021/Pr050281F | 0.34 | |||
| 2006 | Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, Vaugeois JM, Nomikos GG, Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science (New York, N.Y.). 311: 77-80. PMID 16400147 DOI: 10.1126/science.1117571 | 0.781 | |||
| 2006 | Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ. Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 555-62. PMID 16123776 DOI: 10.1038/Sj.Npp.1300832 | 0.638 | |||
| 2005 | Svenningsson P, Nairn AC, Greengard P. DARPP-32 mediates the actions of multiple drugs of abuse. The Aaps Journal. 7: E353-60. PMID 16353915 DOI: 10.1208/aapsj070235 | 0.611 | |||
| 2005 | Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, Svenningsson P, Fredholm BB, Borrelli E, Greengard P, Fisone G. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8432-8. PMID 16162925 DOI: 10.1523/Jneurosci.1289-05.2005 | 0.645 | |||
| 2005 | Chergui K, Svenningsson P, Greengard P. Physiological role for casein kinase 1 in glutamatergic synaptic transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 6601-9. PMID 16014721 DOI: 10.1523/JNEUROSCI.1082-05.2005 | 0.76 | |||
| 2005 | Ryan XP, Alldritt J, Svenningsson P, Allen PB, Wu GY, Nairn AC, Greengard P. The Rho-specific GEF Lfc interacts with neurabin and spinophilin to regulate dendritic spine morphology. Neuron. 47: 85-100. PMID 15996550 DOI: 10.1016/j.neuron.2005.05.013 | 0.55 | |||
| 2005 | Pierson J, Svenningsson P, Caprioli RM, Andren PE. Increased levels of ubiquitin in the 6-OHDA-lesioned striatum of rats. Journal of Proteome Research. 4: 223-6. PMID 15822896 DOI: 10.1021/Pr049836H | 0.381 | |||
| 2005 | Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM. Adenosine and brain function. International Review of Neurobiology. 63: 191-270. PMID 15797469 DOI: 10.1016/S0074-7742(05)63007-3 | 0.625 | |||
| 2005 | Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol JC, Stipanovich A, Caboche J, Lombroso PJ, Nairn AC, Greengard P, Hervé D, Girault JA. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proceedings of the National Academy of Sciences of the United States of America. 102: 491-6. PMID 15608059 DOI: 10.1073/Pnas.0408305102 | 0.77 | |||
| 2004 | Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P. The role of DARPP-32 in the actions of drugs of abuse. Neuropharmacology. 47: 14-23. PMID 15464122 DOI: 10.1016/J.Neuropharm.2004.05.010 | 0.676 | |||
| 2004 | Lee SJ, Romeo RD, Svenningsson P, Campomanes CR, Allen PB, Greengard P, McEwen BS. Estradiol affects spinophilin protein differently in gonadectomized males and females. Neuroscience. 127: 983-8. PMID 15312910 DOI: 10.1016/j.neuroscience.2004.05.049 | 0.415 | |||
| 2004 | Pierson J, Norris JL, Aerni HR, Svenningsson P, Caprioli RM, Andrén PE. Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. Journal of Proteome Research. 3: 289-95. PMID 15113106 DOI: 10.1021/Pr0499747 | 0.304 | |||
| 2004 | Allen PB, Greenfield AT, Svenningsson P, Haspeslagh DC, Greengard P. Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. Proceedings of the National Academy of Sciences of the United States of America. 101: 7187-92. PMID 15107502 DOI: 10.1073/pnas.0401673101 | 0.44 | |||
| 2004 | Chergui K, Svenningsson P, Greengard P. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proceedings of the National Academy of Sciences of the United States of America. 101: 2191-6. PMID 14769920 DOI: 10.1073/pnas.0308652100 | 0.789 | |||
| 2004 | Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. DARPP-32: an integrator of neurotransmission. Annual Review of Pharmacology and Toxicology. 44: 269-96. PMID 14744247 DOI: 10.1146/Annurev.Pharmtox.44.101802.121415 | 0.687 | |||
| 2004 | Svenningsson P. Response to Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway" Science. 305: 180d-180d. DOI: 10.1126/SCIENCE.1097564 | 0.329 | |||
| 2004 | Svenningsson P, Tzavara E, Fienberg A, Nomikos G, Greengard P. P.1.10 Diverse psychotomimetics act through a common signaling pathway European Neuropsychopharmacology. 14: S9-S10. DOI: 10.1016/S0924-977X(04)90011-9 | 0.339 | |||
| 2004 | Svenningsson P, Tzavara E, Carruthers R, Nomikos G, Greengard P. S.04.01 Diverse psychotomimetics act through a common signaling pathway European Neuropsychopharmacology. 14: S117-S118. DOI: 10.1016/S0924-977X(04)80012-9 | 0.395 | |||
| 2003 | Fukui R, Svenningsson P, Matsuishi T, Higashi H, Nairn AC, Greengard P, Nishi A. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. Journal of Neurochemistry. 87: 1391-401. PMID 14713295 DOI: 10.1046/j.1471-4159.2003.02101.x | 0.623 | |||
| 2003 | Svenningsson P, Fredholm BB. Exciting news about A2A receptors. Neurology. 61: S10-1. PMID 14663002 DOI: 10.1212/01.WNL.0000095203.52609.6A | 0.531 | |||
| 2003 | Fredholm BB, Svenningsson P. Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology. 61: S5-9. PMID 14663001 DOI: 10.1212/01.WNL.0000095204.89871.FF | 0.562 | |||
| 2003 | Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science (New York, N.Y.). 302: 1412-5. PMID 14631045 DOI: 10.1126/science.1089681 | 0.514 | |||
| 2003 | Fredholm BB, Cunha RA, Svenningsson P. Pharmacology of adenosine A2A receptors and therapeutic applications. Current Topics in Medicinal Chemistry. 3: 413-26. PMID 12570759 DOI: 10.2174/1568026033392200 | 0.627 | |||
| 2003 | Svenningsson P, Tzavara E, Nomikos G, McEwen B, Greengard P. S.04.02 Biochemical modulation of AMPA receptor function by antidepressants European Neuropsychopharmacology. 13: S102-S103. DOI: 10.1016/S0924-977X(03)91610-5 | 0.478 | |||
| 2002 | Svenningsson P, Arts J, Gunne L, Andren PE. Acute and repeated treatment with L-DOPA increase c-jun expression in the 6-hydroxydopamine-lesioned forebrain of rats and common marmosets. Brain Research. 955: 8-15. PMID 12419516 DOI: 10.1016/S0006-8993(02)03289-4 | 0.329 | |||
| 2002 | Klintenberg R, Svenningsson P, Gunne L, Andrén PE. Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 1295-307. PMID 12373562 DOI: 10.1007/s00702-002-0715-6 | 0.325 | |||
| 2002 | Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, Fredholm BB, Nairn AC, Greengard P, Fisone G. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature. 418: 774-8. PMID 12181566 DOI: 10.1038/Nature00817 | 0.767 | |||
| 2002 | Svenningsson P, Tzavara ET, Liu F, Fienberg AA, Nomikos GG, Greengard P. DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proceedings of the National Academy of Sciences of the United States of America. 99: 3188-93. PMID 11880652 DOI: 10.1073/pnas.052712699 | 0.52 | |||
| 2002 | Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, Nomikos GG, Greengard P. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proceedings of the National Academy of Sciences of the United States of America. 99: 3182-7. PMID 11880651 DOI: 10.1073/Pnas.052712799 | 0.531 | |||
| 2002 | Svenningsson P, Le Moine C. Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptors. The European Journal of Neuroscience. 15: 133-42. PMID 11860513 DOI: 10.1046/j.0953-816x.2001.01840.x | 0.392 | |||
| 2001 | Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature. 410: 376-80. PMID 11268215 DOI: 10.1038/35066591 | 0.784 | |||
| 2001 | Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Ådén U, Svenningsson P. Adenosine receptor signaling in vitro and in vivo Drug Development Research. 52: 274-282. DOI: 10.1002/Ddr.1124 | 0.697 | |||
| 2000 | Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K, Svenningsson P, Fienberg AA, Greengard P. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8443-51. PMID 11069952 DOI: 10.1523/Jneurosci.20-22-08443.2000 | 0.524 | |||
| 2000 | Svenningsson P, Gunne L, Andren PE. L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset. Neuroscience. 99: 457-68. PMID 11029538 DOI: 10.1016/S0306-4522(00)00213-X | 0.376 | |||
| 2000 | Kull B, Svenningsson P, Fredholm BB. Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Molecular Pharmacology. 58: 771-7. PMID 10999947 DOI: 10.1124/Mol.58.4.771 | 0.494 | |||
| 2000 | Kull B, Svenningsson P, Hall H, Fredholm BB. GTP differentially affects antagonist radioligand binding to adenosine A(1) and A(2A) receptors in human brain. Neuropharmacology. 39: 2374-80. PMID 10974321 DOI: 10.1016/S0028-3908(00)00081-2 | 0.498 | |||
| 2000 | Svenningsson P, Fredholm BB, Bloch B, Le Moine C. Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons. Neuroscience. 98: 749-57. PMID 10891618 DOI: 10.1016/S0306-4522(00)00155-X | 0.489 | |||
| 2000 | Svenningsson P, Fienberg AA, Allen PB, Moine CL, Lindskog M, Fisone G, Greengard P, Fredholm BB. Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32. Journal of Neurochemistry. 75: 248-57. PMID 10854268 DOI: 10.1046/J.1471-4159.2000.0750248.X | 0.653 | |||
| 2000 | Bibb JA, Yan Z, Svenningsson P, Snyder GL, Pieribone VA, Horiuchi A, Nairn AC, Messer A, Greengard P. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proceedings of the National Academy of Sciences of the United States of America. 97: 6809-14. PMID 10829080 DOI: 10.1073/Pnas.120166397 | 0.802 | |||
| 2000 | Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proceedings of the National Academy of Sciences of the United States of America. 97: 1856-60. PMID 10677546 DOI: 10.1073/Pnas.97.4.1856 | 0.641 | |||
| 1999 | Kull B, Ferré S, Arslan G, Svenningsson P, Fuxe K, Owman C, Fredholm BB. Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochemical Pharmacology. 58: 1035-45. PMID 10509756 DOI: 10.1016/S0006-2952(99)00184-7 | 0.548 | |||
| 1999 | Svenningsson P, Le Moine C, Fisone G, Fredholm BB. Distribution, biochemistry and function of striatal adenosine A2A receptors. Progress in Neurobiology. 59: 355-96. PMID 10501634 DOI: 10.1016/S0301-0082(99)00011-8 | 0.487 | |||
| 1999 | Lindskog M, Svenningsson P, Fredholm B, Greengard P, Fisone G. Mu- and delta-opioid receptor agonists inhibit DARPP-32 phosphorylation in distinct populations of striatal projection neurons. The European Journal of Neuroscience. 11: 2182-6. PMID 10336688 DOI: 10.1046/J.1460-9568.1999.00597.X | 0.62 | |||
| 1999 | Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience. 88: 1005-8. PMID 10336115 DOI: 10.1016/S0306-4522(98)00411-4 | 0.627 | |||
| 1999 | Svenningsson P, Nomikos GG, Fredholm BB. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 4011-22. PMID 10234030 DOI: 10.1523/Jneurosci.19-10-04011.1999 | 0.517 | |||
| 1999 | Svenningsson P, Fourreau L, Bloch B, Fredholm BB, Gonon F, Le Moine C. Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons. Neuroscience. 89: 827-37. PMID 10199616 DOI: 10.1016/S0306-4522(98)00403-5 | 0.55 | |||
| 1998 | Svenningsson P, Le Moine C, Aubert I, Burbaud P, Fredholm BB, Bloch B. Cellular distribution of adenosine A2A receptor mRNA in the primate striatum. The Journal of Comparative Neurology. 399: 229-40. PMID 9721905 DOI: 10.1002/(SICI)1096-9861(19980921)399:2<229::AID-CNE6>3.0.CO;2-2 | 0.528 | |||
| 1998 | Svenningsson P, Nergårdh R, Fredholm BB. Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat. Neuropharmacology. 37: 331-7. PMID 9681931 DOI: 10.1016/S0028-3908(98)00045-8 | 0.495 | |||
| 1998 | Fredholm BB, Svenningsson P. Striatal adenosine A2A receptors--where are they? What do they do? Trends in Pharmacological Sciences. 19: 46-8. PMID 9550940 DOI: 10.1016/S0165-6147(97)01160-7 | 0.514 | |||
| 1998 | Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience. 84: 223-8. PMID 9522376 DOI: 10.1016/S0306-4522(97)00510-1 | 0.642 | |||
| 1998 | Fredholm BB, Arslan G, Kuli B, Svenningsson P. Locating the neuronal targets for caffeine Drug Development Research. 45: 324-328. DOI: 10.1002/(Sici)1098-2299(199811/12)45:3/4<324::Aid-Ddr31>3.0.Co;2-1 | 0.555 | |||
| 1997 | Chergui K, Svenningsson P, Nomikos GG, Gonon F, Fredholm BB, Svennson TH. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. The European Journal of Neuroscience. 9: 2370-82. PMID 9464931 DOI: 10.1111/J.1460-9568.1997.Tb01654.X | 0.53 | |||
| 1997 | Svenningsson P, Georgieva J, Kontny E, Heilig M, Fredholm BB. Involvement of a c-fos-dependent mechanism in caffeine-induced expression of the preprotachykinin A and neurotensin/neuromedin N genes in rat striatum. The European Journal of Neuroscience. 9: 2135-41. PMID 9421173 DOI: 10.1111/J.1460-9568.1997.Tb01380.X | 0.471 | |||
| 1997 | Svenningsson P, Hall H, Sedvall G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse (New York, N.Y.). 27: 322-35. PMID 9372555 DOI: 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E | 0.608 | |||
| 1997 | Svenningsson P, Fredholm BB. Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus. Neuropharmacology. 36: 1309-17. PMID 9364486 DOI: 10.1016/S0028-3908(97)00091-9 | 0.545 | |||
| 1997 | Le Moine C, Svenningsson P, Fredholm BB, Bloch B. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 8038-48. PMID 9315922 DOI: 10.1523/Jneurosci.17-20-08038.1997 | 0.517 | |||
| 1997 | Svenningsson P, Le Moine C, Kull B, Sunahara R, Bloch B, Fredholm BB. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience. 80: 1171-85. PMID 9284069 DOI: 10.1016/S0306-4522(97)00180-2 | 0.514 | |||
| 1997 | Svenningsson P, Nomikos GG, Ongini E, Fredholm BB. Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience. 79: 753-64. PMID 9219939 DOI: 10.1016/S0306-4522(97)00046-8 | 0.501 | |||
| 1997 | Kontny E, Ciruela F, Svenningsson P, Ibáñez CF, Fredholm BB. On the role of the low-affinity neurotrophin receptor p75LNTR in nerve growth factor induction of differentiation and AP 1 binding activity in PC12 cells. Journal of Molecular Neuroscience : Mn. 8: 29-44. PMID 9061613 DOI: 10.1007/Bf02736861 | 0.46 | |||
| 1997 | Svenningsson P, Fredholm BB. Glucocorticoids regulate the expression of adenosine A1 but not A(2A) receptors in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 280: 1094-101. PMID 9023328 | 0.434 | |||
| 1996 | Ferre S, O'Connor WT, Svenningsson P, Bjorklund L, Lindberg J, Tinner B, Stromberg I, Goldstein M, Ogren SO, Ungerstedt U, Fredholm BB, Fuxe K. Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. The European Journal of Neuroscience. 8: 1545-53. PMID 8758962 DOI: 10.1111/J.1460-9568.1996.Tb01617.X | 0.553 | |||
| 1996 | Svenningsson P, Johansson B, Fredholm BB. Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801. Brain Research. Molecular Brain Research. 35: 183-9. PMID 8717354 DOI: 10.1016/0169-328X(95)00202-4 | 0.511 | |||
| 1996 | Fernandez M, Svenningsson P, Fredholm BB. Adaptive changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine. Life Sciences. 58: 769-76. PMID 8632724 DOI: 10.1016/0024-3205(95)02355-0 | 0.51 | |||
| 1996 | Ongini E, Dionisotti S, Morelli M, Ferr� S, Svenningsson P, Fuxe K, Fredholm BB. Neuropharmacology of the adenosine A2A receptors Drug Development Research. 39: 450-460. DOI: 10.1002/(SICI)1098-2299(199611/12)39:3/4<450::AID-DDR27>3.0.CO;2-3 | 0.527 | |||
| 1996 | Fredholm BB, Arslan G, Kull B, Kontny E, Svenningsson P. Adenosine (P1) receptor signalling Drug Development Research. 39: 262-268. DOI: 10.1002/(SICI)1098-2299(199611/12)39:3/4<262::AID-DDR5>3.0.CO;2-P | 0.492 | |||
| 1995 | Svenningsson P, Ström A, Johansson B, Fredholm BB. Increased expression of c-jun, junB, AP-1, and preproenkephalin mRNA in rat striatum following a single injection of caffeine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 3583-93. PMID 7751931 DOI: 10.1523/Jneurosci.15-05-03583.1995 | 0.454 | |||
| 1995 | Svenningsson P, Johansson B, Fredholm BB. Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum. Acta Physiologica Scandinavica. 154: 17-24. PMID 7572198 DOI: 10.1111/j.1748-1716.1995.tb09881.x | 0.478 | |||
| 1995 | Svenningsson P, Nomikos GG, Fredholm BB. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 7612-24. PMID 7472512 DOI: 10.1523/Jneurosci.15-11-07612.1995 | 0.509 | |||
| 1992 | Johansson B, Svenningsson P, Adén U, Lindström K, Fredholm BB. Evidence that the increase in striatal c-fos following acute high-dose caffeine is not due to direct interaction with striatal adenosine receptors. Acta Physiologica Scandinavica. 146: 539-41. PMID 1492572 DOI: 10.1111/j.1748-1716.1992.tb09461.x | 0.494 | |||
| Show low-probability matches. | |||||